Current treatment: options for continuing or switching

Oral bisphosphonates
Continue or switch to intravenous bisphosphonates
Intravenous bisphosphonates
Continue
Denosumab
Continue
Selective estrogen receptor modulator (SERM, eg, raloxifene)
Drug holiday for 35 days
Strontium ranelate
Switch to intravenous bisphosphonate
Teriparatide, PTH
Continue (up to a maximum of 24 months from initiation)
<%= buttons %>